Become a global leader in contrast agents
Established in 1997, Zhejiang Starry Pharmaceutical Co., Ltd. is a high-tech enterprise specialized in research and development, production and sales of X-CT nonionic iodine contrast agent series and quinolone series bulk drugs and intermediates. It is currently the production base of diagnostic bulk drugs in China. The company was listed on the Shanghai Stock Exchange on March 9, 2016 (Stock Code: 603520).
Shanghai Stock Exchange
A global professional contrast agent high-tech enterprise, Starry Pharm has a number of production bases and sales companies both at home and abroad, mainly including Jiangxi Starry, Shanghai Starry, Haishen Pharmaceutical and Irish IMAX.
seek perfection in a down-to-earth manner
Strategic achievements of the company
Using new technology for sustainable innovation of human health